4.7 Article

Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

et al.

JOURNAL OF HEPATOLOGY (2015)

Article Gastroenterology & Hepatology

Yttrium-90 Radioembolization for Intermediate-Advanced Hepatocellular Carcinoma: A Phase 2 Study

Vincenzo Mazzaferro et al.

HEPATOLOGY (2013)

Article Gastroenterology & Hepatology

Safety and effectiveness of sorafenib in patients with hepatocellular carcinoma in clinical practice

Giovan Giuseppe Di Costanzo et al.

DIGESTIVE AND LIVER DISEASE (2012)

Review Gastroenterology & Hepatology

Radioembolization for hepatocellular carcinoma

Bruno Sangro et al.

JOURNAL OF HEPATOLOGY (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib

Matthias Pinter et al.

RADIOLOGY (2012)

Review Oncology

General Selection Criteria of Patients for Radioembolization of Liver Tumors An International Working Group Report

Douglas Coldwell et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2011)

Review Gastroenterology & Hepatology

Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection

W. Alazawi et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)

Article Oncology

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Jacques Ferlay et al.

INTERNATIONAL JOURNAL OF CANCER (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

Use of Yttrium-90 Microspheres in Patients with Advanced Hepatocellular Carcinoma and Portal Vein Thrombosis

Andrea Lan Tsai et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of Yttrium-90 Radioembolization and Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma

David A. Kooby et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2010)

Review Gastroenterology & Hepatology

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

Riccardo Lencioni et al.

SEMINARS IN LIVER DISEASE (2010)

Article Oncology

TREATMENT PARAMETERS AND OUTCOME IN 680 TREATMENTS OF INTERNAL RADIATION WITH RESIN 90Y-MICROSPHERES FOR UNRESECTABLE HEPATIC TUMORS

Andrew S. Kennedy et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)

Review Gastroenterology & Hepatology

Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents

M. Chaparro et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)

Review Gastroenterology & Hepatology

Novel advancements in the management of hepatocellular carcinoma in 2008

Josep M. Llovet et al.

JOURNAL OF HEPATOLOGY (2008)

Article Medicine, General & Internal

Sorafenib in advanced hepatocellular carcinoma

Josep M. Llovet et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Gastroenterology & Hepatology

Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma

Kiminori Uka et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2007)

Review Gastroenterology & Hepatology

Management of hepatoceullular carcinoma

J Bruix et al.

HEPATOLOGY (2005)

Review Oncology

Pathologic response and microdosimetry of 90Y microspheres in man:: Review of four explanted whole livers

AS Kennedy et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)